Sanguinaria canadensis
Sanguinaria canadensis · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Sanguinaria canadensis, commonly known as bloodroot, is a perennial herb valued for its medicinal properties found primarily within its rhizome and root. The plant contains the potent benzophenanthridine alkaloid known as sanguinarine, which has demonstrated significant biological activities. Research suggests its chemical profile offers anticancer potential and acts as a 5-lipoxygenase inhibitor, making it relevant for treating conditions such as skin cancer, moles, and actinic keratoses. Furthermore, its inotropic and anti-inflammatory effects have drawn interest for managing respiratory issues like asthma. Scientists continue to study the plant through various preparations, including methanolic extracts and cell suspension cultures, to develop specialized treatments like blemish creams.
- Synonyms
- Sanguinaria Grandiflora · Belharnosia Mesochora · 10 more
- Common names
- Not available
- Family
- Papaveraceae
- Distribution
- Asia-Tropical
- Plant Parts
- Rhizome · Root
Classification
Common Names
Sanguinaria canadensis is a distinctive woodland perennial known by a wide variety of regional and linguistic names. In English-speaking areas, it is most commonly referred to as Bloodroot, though it has also been called Blodrot or Blodurt. The plant's diverse nomenclature extends into other linguistic variations, such as the name Bloedwortel. Some specific regional traditions even identify the species as Canadisk Blodurt. These many names reflect the plant's long-standing presence and cultural recognition across different communities.
Sources: Catalogue of Life (COL)
Synonyms
Sanguinaria canadensis is a botanical subject characterized by a complex history of taxonomic nomenclature. Throughout various scientific records, the species has been identified under several different synonyms, including Belharnosia canadensis and Belharnosia mesochora. Researchers have also documented the plant under the names Sanguinaria acaulis and Sanguinaria australis. Furthermore, specific morphological variations are recognized through the designation Sanguinaria canadensis f. multiplex. Understanding these various botanical relationships is essential for accurate identification and classification within the plant kingdom.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Sanguinaria canadensis is a unique botanical specimen that belongs to the vast kingdom Plantae. Within this kingdom, it is categorized under the class Equisetopsida and the order Ranunculales. This plant is further distinguished by its membership in the family Papaveraceae. Its specific biological classification is defined by its placement within the genus Sanguinaria. Through these various taxonomic relationships, one can better understand its complex position in the natural world.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ranunculales |
| Family | Papaveraceae |
| Genus | Sanguinaria |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Sanguinaria canadensis is widely distributed across much of Northern America, stretching from the vast landscapes of the North-Central United States into the heart of Canada. In the American Midwest, this species can be found thriving in regions such as Illinois. Moving northward, its presence is firmly established throughout the eastern reaches of Canada. Specifically, it populates the diverse terrains of Ontario, Québec, New Brunswick, and Nova Scotia. This broad geographical range highlights the plant's ability to adapt to various temperate environments across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Sanguinaria canadensis grows in a distinct herb form, characterized by its delicate foliage and seasonal blooms. This plant is entirely self-supporting, allowing it to stand firmly within its woodland habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Sanguinaria canadensis is recognized as one of several traditional medicinal plants that play a vital role in modern anticancer drug development. Research indicates that this plant contains bioactive phytoconstituents that exhibit significant anticancer properties. Specifically, components such as sanguinarine derived from the plant have been shown to modulate key signaling pathways, including PI3K/Akt/mTOR and RAS/RAF/MAPK. By targeting these cellular pathways, the plant offers a promising avenue for addressing under-researched malignancies like lung and colorectal cancers. Ultimately, the study of Sanguinaria canadensis highlights the powerful synergy between ancient traditional knowledge and contemporary scientific innovation.
Compounds
Sanguinaria canadensis serves as a vital natural source for the potent benzophenanthridine alkaloid known as sanguinarine. This compound is primarily extracted from the rhizomes of the plant, where it can constitute a significant portion of the dry weight. Researchers have identified that sanguinarine possesses remarkable biological activities, making it a subject of intense interest for modern drug development. Because of its ability to interact with DNA and various functional proteins, it shows great therapeutic potential for treating chronic diseases such as cancer and asthma. Ongoing studies continue to explore how to optimize the accumulation of this important alkaloid through specialized cultivation and elicitation techniques.
Conditions
Sanguinaria canadensis is traditionally used as a medicinal plant to treat a diverse range of clinical conditions. Within dermatological applications, the plant is popularly marketed as a remedy to treat moles and various skin lesions. Preclinical research has also indicated that its active components show promise in the effort to treat skin cancer. Furthermore, derivatives of its alkaloids have demonstrated significant antibacterial activity against Staphylococcus aureus. The plant's bioactive compounds also show efficacy in treating Enterococcus faecalis, including multidrug-resistant strains.
Preparations
Sanguinaria canadensis is prepared as blemish cream, a product marketed as a natural remedy for various skin conditions. This plant is also prepared as cell suspension cultures to study the accumulation of benzophenanthridine alkaloids through elicitation protocols. Researchers utilize Sanguinaria canadensis prepared as plant cell cultures to conduct immunoblot analyses for purifying specific enzymes like dihydrobenzophenanthridine oxidase. Additionally, Sanguinaria canadensis is prepared as methanolic extracts, which have demonstrated significant egg-hatch inhibition in anthelmintic activity screenings. These diverse preparations allow for the investigation of the plant's biochemical properties and medicinal applications.
Parts used
Sanguinaria canadensis, commonly known as bloodroot, is a plant species highly valued for its unique phytochemical properties. Scientific research highlights that the plant's rhizome serves as a primary source for several bioactive alkaloids. Specifically, the sanguinarine alkaloid is found in significant concentrations within these rhizomatous structures. Because the rhizome is a specialized type of underground root, it functions as the central reservoir for these medicinal compounds. Understanding the relationship between the plant and its root system is essential for exploring its therapeutic potential and historical medicinal uses.